Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
https://doi.org/10.4081/dr.2023.9668
HTML: 15
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Primary and booster vaccines for SARS-CoV-2 are the most effective methods of preventing infection and are generally considered safe. However, many cutaneous adverse events have been reported following vaccination. To date, there have been seven reported cases of Sweet syndrome occurring after the first dose of the SARS-CoV-2 vaccine. We describe a rare case of atypical giant-cellulitis like Sweet syndrome reemerging after receiving the SARS-CoV-2 booster vaccine.
Rochet NM, Chavan RN, Cappel MA, et al. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69:557-64. DOI: https://doi.org/10.1016/j.jaad.2013.06.023
Nelson CA, Stephen S, Ashchyan HJ, et al. Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease. J Am Acad Dermatol. 2018;79:987-1006. DOI: https://doi.org/10.1016/j.jaad.2017.11.064
Darrigade AS, Théophile H, Sanchez-Pena P, et al. Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine. Allergy. 2021;76:3194-3196. DOI: https://doi.org/10.1111/all.14981
Baffa ME, Maglie R, Giovannozzi N, et al. Sweet syndrome following SARS-CoV2 Vaccination. Vaccines (Basel). 2021;9:1212. DOI: https://doi.org/10.3390/vaccines9111212
Majid I, Mearaj S. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female. Dermatol Ther. 2021;34:e15146. DOI: https://doi.org/10.1111/dth.15146
Ben Rejeb S, Beltaifa D, Dhaoui A, et al. SARS-CoV-2 vaccine induced Sweet syndrome : a case report. Tunis Med. 2021;99:1188-1191.
Torrealba-Acosta G, Martin JC, Huttenbach Y, et al. Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep. 2021;14:e243173. DOI: https://doi.org/10.1136/bcr-2021-243173
Hoshina D, Orita A. Sweet syndrome after severe acute respiratory syndrome coronavirus 2 mRNA vaccine: A case report and literature review. J Dermatol. 2022;49:e175-e176. DOI: https://doi.org/10.1111/1346-8138.16309
Pelchat F, Fournier C, Perron E, et al. Sweet syndrome following Moderna COVID-19 vaccine: A case report. SAGE Open Med Case Rep. 2022;10:2050313X221117884. DOI: https://doi.org/10.1177/2050313X221117884
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
